Home > National Drug Code (NDC) > Sandostatin

Sandostatin - 0078-0181-01 - (octreotide acetate)

Alphabetical Index


Drug Information of Sandostatin

Product NDC: 0078-0181
Proprietary Name: Sandostatin
Non Proprietary Name: octreotide acetate
Active Ingredient(s): 100    ug/mL & nbsp;   octreotide acetate
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Sandostatin

Product NDC: 0078-0181
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019667
Marketing Category: NDA
Start Marketing Date: 19881021

Package Information of Sandostatin

Package NDC: 0078-0181-01
Package Description: 10 AMPULE in 1 PACKAGE (0078-0181-01) > 1 mL in 1 AMPULE (0078-0181-61)

NDC Information of Sandostatin

NDC Code 0078-0181-01
Proprietary Name Sandostatin
Package Description 10 AMPULE in 1 PACKAGE (0078-0181-01) > 1 mL in 1 AMPULE (0078-0181-61)
Product NDC 0078-0181
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name octreotide acetate
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 19881021
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name OCTREOTIDE ACETATE
Strength Number 100
Strength Unit ug/mL
Pharmaceutical Classes Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]

Complete Information of Sandostatin


General Information